Právní předpis byl sestaven k datu 29.04.2025.
Zobrazené znění právního předpisu je účinné od 01.04.2025.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
č. 194/2021 Sb. - Čl. II
č. 159/2022 Sb. - Čl. II
č. 228/2023 Sb. - Čl. II
č. 52/2024 Sb. - Čl. II
č. 176/2024 Sb. - Čl. II
č. 419/2024 Sb. - Čl. II
463
XXXXXXXX XXXXX
xx xxx 18. prosince 2013
o xxxxxxxxx xxxxxxxxxx látek
Vláda xxxxxxxx xxxxx §44c xxxx. 1 zákona x. 167/1998 Xx., x xxxxxxxxxx látkách x o xxxxx xxxxxxxxx dalších xxxxxx, xx xxxxx xxxxxx x. 273/2013 Xx.:
§1
Xxxx xxxxxxxx xxxxxxx
x) x příloze č. 1 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxxxx úmluvy x xxxxxxxx xxxxxxx1) x
2. dalších xxxxxxxx xxxxx, s xxxxx xx x důvodu xxxxxxx xxxxxx zneužívání xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx jen xx xxxxxxx xxxxxxxx x zacházení, xxxx xx x xxxxxx xxxxxx xxxxx xxxxxxxxxx, xxx léčivé xxxxxxxxx xxxxxxxxxx xxxx omamné xxxxx byly vydávány x xxxxxxx xxxxx xx xxxxxx xxxx xxxxxxx xxxxxxxx modrým xxxxxx směřujícím z xxxxxx dolního xxxx xx xxxxxxx xxxxxxx xxxx,
(xxxx xxx "seznam x. 1 xxxxxxxx xxxxx"),
x) v příloze č. 2 x tomuto xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Jednotné xxxxxx o omamných xxxxxxx a
2. dalších xxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, xxx xxxxxx přípravky xxxxxxxxxx xxxx xxxxxx látky xxxx vydávány v xxxxxxx xx xxxxxx xxxx xxxxxxx xxx xxxxxxxx xxxxxx xxxxxx,
(xxxx xxx "xxxxxx č. 2 omamných xxxxx"),
x) x příloze č. 3 k xxxxxx nařízení xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx x omamných látkách x
2. xxxxxxx xxxxxxxx xxxxx, u nichž xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx xxxxxx, nutné xxxxxxxxxx, xxx xxxxx x xxxxxxxxx xxxxxxxxxx xxxx omamné xxxxx xxxx xxxxxxxxx pouze x xxxxxxxx xxxxxxxxx, xxxxxxxx a xxxxx xxxxxxxx terapeutickým účelům xxxxxxxxx x xxxxxxxx x zacházení,
(dále xxx "xxxxxx x. 3 xxxxxxxx xxxxx"),
x) x příloze č. 4 k xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx do Xxxxxxx X xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx nebo xxxxxxx ohrožují xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxx a xxxxxxxxx xxxxxxxxxx tyto xxxxxxxxxxxx xxxxx xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx x xxxxxxxx k xxxxxxxxx,
(xxxx xxx "seznam x. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx II xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx a
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx zneužívání xxxxx xxxxx, že bezprostředně xxxx nepřímo xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx jen na xxxxxxx povolení k xxxxxxxxx, xxxx xx x xxxxxx xxxxxx xxxxx zabezpečit, aby xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxxx xxxxxxxx x xxxxxxx pouze na xxxxxx xxxx xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx xxxx xx xxxxxxx xxxxxxx rohu,
(dále xxx "seznam x. 5 psychotropních látek"),
f) x příloze č. 6 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Seznamu XXX xxxxx Úmluvy x xxxxxxxxxxxxxx xxxxxxx,
x) x příloze č. 7 x xxxxxx xxxxxxxx seznam
1. xxxxxxxxxxxxxx xxxxx zařazených xx Xxxxxxx XX xxxxx Xxxxxx o xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx obsahující xxxx xxxxx xxxx xxxxxxxx x lékárně xx recept xxxx xxxxxxx bez xxxxxxxx xxxxxx xxxxxx,
(xxxx xxx "xxxxxx x. 7 xxxxxxxxxxxxxx látek"), x
x) x příloze č. 8 x xxxxxx nařízení xxxxxx xxxxxxxxx xxxxxxxxxx do Xxxxxxx III xxxxx Xxxxxxxx xxxxxx x xxxxxxxx látkách,
(dále xxx "xxxxxx č. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Xxxx nařízení xxxx oznámeno x xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx a Xxxx 98/34/ES xx xxx 22. xxxxxx 1998 x postupu xxx poskytování xxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxxx x předpisů xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx, x platném znění.
(2) Xxxx xxxxxxxx xxxxxxxxxxx xxxxxxxxx předpisy Xxxxxxxx xxxx xxxxxxxx se xxxxxxxxxx xxxxx3).
§3
Xxxx nařízení xxxxxx xxxxxxxxx xxxx 1. xxxxx 2014.
Xxxxxxx č. 1 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 1 omamných xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx |
Xxxxxxxx název xxxxx IUPAC |
Poznámka |
Acetorfin |
(5R,6R,7R)-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-4,5-epoxy-6,14-ethenomorfinan-3-yl-acetát |
|
Acetyl-alfa-methylfentanyl |
(RS)-N-[1-(2-fenyl-2-methylethyl)-4-pipendyl]acetanihd |
|
Acetylmethadol |
(3RS)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát |
|
Alfacetylmethadol |
(3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát |
|
Alfameprodin |
(3RS,4RS)-3-ethyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
Alfamethadol |
(3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol |
|
Alfa-methylfentanyl |
N-{1-[(1RS)-2-fenyl-1-methylethyl]piperidin-4-yl}propananilid |
|
Alfa-methylthiofentanyl |
N-{1-[(1RS)-1-methyl-2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
Alfaprodin |
(3RS,4SR)-4-fenyl-1,3-dimethy piperidin-4-yl-propanoát |
|
Alfentanil |
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-fenylpropanamid |
|
Allylprodin |
3-allyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
Anileridin |
ethyl-1-(4-aminofenethyl)-4-fenylpiperidin-4-karboxylát |
|
Benzethidin |
ethyl-1-[2-(benzyloxy)ethyl]-4-fenylpiperidin-4-karboxylát |
|
Benzylmorfin |
3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6α-ol |
|
Betacetylmethadol |
(3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát |
|
Beta-hydroxyfentanyl |
N-{1-[(2RS)-2-hydroxyfenethyl]piperidin-4-yl}propananilid |
|
Beta-hydroxymethylfentanyl |
N-{1-[(2RS)-2-hydroxyfenethyl]-3-methylpiperidin-4-yl}propananilid |
|
Betameprodin |
(3RS,4RS)-3-ethyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
Betamethadol |
(3S,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol |
|
Betaprodin |
(3RS,4RS)-4-fenyl-1,3-dimethylpiperidin-4-yl-propanoát |
|
Bezitramid |
2,2-difenyl-4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1H-benzimidazol-1-yl)piperidino]butannitril |
|
Dextromoramid |
1-[(3S)-2,2-difenyl-3-methyl-4-morfolinobutanoyl]pyrrolidin |
|
Diampromid |
N-[2-(N-fenethyl-N-methylamino)propyl]propananilid |
|
Diethylthiambuten |
3-(diethylamino)-1,1-di(2-thienyl)but-1-en |
|
Difenoxin |
1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylová xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
(5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
Xxxxxxx |
xxxxxxxx (l.R.2R,3S5S)3-hydroxy-8-methyl-8-azabicyklo[3.2.1]oktan-2-karboxylová, xxxx xxxxxx x xxxxxxxx, x kterých xx xxxxx xxxxxx ekgonin x kokain |
|
Ethylmethylthiambuten |
N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin |
|
Etonitazen |
1-[2-(diethylamino)ethyl]-2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol |
|
Etoxeridin |
ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát |
|
Extrakt z xxxxxx xxx léčebné xxxxxxx |
Xxxxxxx z konopí xxxxxxxx x přípravě xxxxxxxx xxxxxxxxx xx xxxxxxxxxxxxxxxx obsahem xxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx |
|
Xxxxxxxxx |
(2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
|
Xxxxxxxxxx |
17-xxxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xxxxxx)xxxxx]xxx}xxxxxx |
|
Xxxx - xxxx |
Xxxxxx xxxx |
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxx z xxxxxxxx |
Xxxxxxxxxxx x výrobě alkaloidů xxxxxxx technologickou úpravou xxxxxxxx |
|
Xxxxxx xxxxxxx a xxxxxxxx |
X xxxxxxxx xxxxx xxxxxx xxxxxxx x xxxxxxxx, která xxxxxxxx 1 % xxxxx xx skupiny tetrahydrokanabinolů x xxxxxxx podmínku xxxxxxxxxxx xxxxx zákona x obecné xxxxxxxxxxx xxxxxxx |
|
Xxxxxx xxx xxxxxxx xxxxxxx |
||
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx dextromethorfan [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx v xxxx xxxxxxx |
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxxx [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx ze xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx |
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3-xxxxxxxxx-8-xx |
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
Xxxxxxx, xxxxxxxxxxx |
2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxx xxxxxxxx |
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
Xxxxxxxxxxx xxxxxx xxx xxxxxxx xxxxxxx |
xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxx xxx xxxxxxx xxxxxxx xxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(2-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx |
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x xxxx xxxxxxxx morfinu xx xxxxxxxxxx dusíkem xxxxxx derivátů morfin-N-oxidu |
Xxxxxx-X-xxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
Xxxxxxxxxxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxx |
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
Xxxxx |
Xxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxxxxxx xxxxxx xxxxxx xx vyšší xxx X4 nebo XX2 |
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxxxxx 4-fenyl-1-methylpiperidin-4-karboxylová |
|
Piminodin |
ethyl-1-(3-anilinopropyl)-4-fenylpiperidin-4-karboxylát |
|
Piritramid |
1'-(3,3-difenyl-3-kyanpropyl)-4'-ureido-1,4'-bipiperidin |
|
Proheptazin |
4-fenyl-1,3-dimethylazepan-4-yl-propanoát |
|
Properidin |
isopropyl-4-fenyl-1-methylpiperidin-4-karboxylát |
|
Racemethorfan |
(9RS,13RS,14RS)-3-methoxy-17-methylmorfinan |
|
Racemoramid |
(3RS)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on |
|
Racemorfan |
(9RS,13RS,14RS)-17-methylmorfinan-3-ol |
|
Remifentanil |
methyl-3-[4-(N-acetonylanilino)-4-(methoxykarbonyl)]piperidino]propanoát |
|
Sufentanil |
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
Tapentadol |
3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]fenol |
|
Thebain |
4,5α-epoxy-3,6-dimethoxy-17-methylmorfína-6,8-dien |
|
Thebakon |
(5R)-4,5-epoxy-3-methoxy-17-methylmorfin-6-en-6-yl-acetát |
|
Thiafentanil | methyl 4-(X-(2-xxxxxxxxxxxxx)xxxxxx)-1-(2-xxxxxxx-2-xxxxxxx)xxxxxxxxx-4-xxxxxxxxxx | X-3080, Xxxxxxx |
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu, xxxx xxxxxx a xxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu x solí xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxxxx xxxx xxxxxxx, xxxxxx x éterů ve xxxxx případech, xxx xxxx soli mohou xxxxxxxxx.
Xxxxxxx č. 2 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 2 omamných xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v českém xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu, xxxx xxxx xxxxxxxx látek xxxxxxxxx x tomto xxxxxxx, včetně xxxx xxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu xx xxxxx případech, xxx xxxx xxxx xxxxx existovat.
Xxxxxxx x. 3 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 3 xxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x&xxxx;xxxxxx xxxxxx / obecný xxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-(1-xxxxxx-xxxxxxxxx-4-xx)-xxxxxxxx |
XXX 73750 |
Acetylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]acetamid |
||
Acryloylfentanyl |
Acrylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]prop-2-enamid |
|
AH-7921 |
3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid |
||
AP-237 |
bucinnazin; 1-X-xxxxxxx-4- xxxxxxxxxxxxxxxxxx; |
1-[4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xx]xxxxx-1-xx |
|
XX-238 |
1-[2,6-xxxxxxxx-4-(3-xxxxxxxxx-2-xxxx)xxxxxxxxx-1-xx]xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxxx |
XXX-X; benzodioxole-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl-1-2H-1,3-benzodioxol-5-karboxamid |
|
Benzoylbenzylfentanyl |
N-fenyl-N-(1-benzyl-piperidin-4-yl)benzamid |
||
Benzoylfentanyl |
fenylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]benzamid |
|
Benzylfentanyl |
Benzyl-F; R4129 |
N-fenyl-N-[1 -(xxxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxx XxX |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxx |
X 4793x; X 47931X |
4-xxxx-X-(2-(xxxxxxxxxxxxx) xxxxxxxxxx) xxxxxxxx |
|
Xxxxxxx |
Xxxxxxxxx |
3-{1-[1-(4-xxxxxxxxx)xxxxx]xxxxxxxxx-4-xx}-1X-xxxxxxxxxxxx-2-xx |
|
Xxxxxxxxxxx |
2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-5-xxxxx-xX-xxxxxxxxxxxx-1-xxxxxxxxx |
||
4-Xxxxxxxxxxxxxxxxxxxxx |
4-Xx-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxx-X; XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxxx |
X530 |
4-(4-xxxxxxxxxx)-2,2-xxxxxxx-1-(1-xxxxxxxxxxxx)-1-xxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
||
Xxxxxxxxxxxx-2-xxxxx xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
Xxxxxxxxxxxx-4-xxxxx xxxxxxxx |
X-(4-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
Xxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxx-1-xx)xxxxxx-3-xx |
||
Xxxxxx |
xxxxxxxxxxxxxx |
2-[2-[(4-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]-X,X-xxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxx |
2-{2-[(2,3-xxxxxxx-1-xxxxxxxxxx-5-xx)xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xx}-X,X- xxxxxxxxxxxx-1-xxxx |
||
Xxxxxxxxxx |
5-xxxxxx etodesnitazen; 5-methyl xxxxxxxxxxxxxxxxxx |
2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-5-xxxxxx-1X-xxxxxxxxxxxx-1-xxxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxxxxxx |
2-(4-xxxxxxxxxxxx)-5-xxxxx-1-(2-(xxxxxxxxx-1-xx)xxxxx)-1X-xxxxx[x]xxxxxxxx |
|
Xxxxxxxxxxxx |
2-[(4-xxxxxxxxxxx)xxxxxx]-5-xxxxx-1-(2-xxxxxxxxxx-1-xxxxxxx)-1X-xxxxxxxxxxxxx |
||
Xxxxxxx |
(5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
||
Xxxxxxxx xxxxxxxxx xxxxxx |
xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
|
3 -Xxxxxxxxxxxxxxxxxxxxx |
β'-xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-x]-3-xxxxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxxxxxxx |
Xxxxxxxxxx |
X,X-xxxxxxx-2-{2-[(4-xxxxxxxxxx)xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xx}xxxxxxxxx |
||
2’-Xxxxx-2-xxxxx-3-xxxxxxxxxxxxxx |
X-(1-(2-xxxxxxxxxxxxx)-3-xxxxxxxxxxxxxxx-4-xx)-X-(2-xxxxxxxxxx)xxxxxxxxxxx |
||
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
4-Xxxxx-xxxxxxxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxxxx- fentanyl |
N-(4-fluorfenyl)-N-(1-benzylpiperidin-4-yl)-cyklopropankarboxamid |
|
2-Fluorfentanyl |
Ortofluorfentanyl |
N-(2-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
2-FF, x-XX |
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
4-Xxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxx; 4X-xxxxxxxxxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxxxx-4-xx)xxxxx-2-xxxxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-1XX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
3-XxxxxxxxxxxxxxxxxXxxxxxxxx |
xxxxx-xxxxxxxxxxxxxxxxxx- xxxxxxxx |
X-(3-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
2X-xxxxxxx |
2-[xx(xxxxx-2-xx)xxxxx]-1-[1-(2-xxxxxxxxxxx)-1X-xxxxxx-2-xx]xxxxx-1-xx |
||
Xxxxxxx XX-17 |
X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxx-xxxxx-2-xxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
XX-X; 2-xxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxx-2-xxxxxxxxxx |
|
(xxx)Xxxxxxx-X-xxxxxxxx N-benzyl xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
||
4-xxxxxxxxxxxxxxxxxxxx |
4-XX-XX; x-xxxxxxxxxxxxxx fentanyl |
N-(4-hydroxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]-butanamid |
|
Isobutyrfentanyl |
2-methyl-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]propanamid |
||
Isopropyl-U-47700 |
3,4-dichlorA-[2-(dimethylamino)cyklohexyl]-N-(propan-2-yl)benzamid |
||
Isotonitazen |
N,N-diethyl-2-[[4-(1-methylethoxy)fenyl]methyl]-5-nitro-1N-benzimidazol-1-ethan xxxx |
||
Xxxxxxxx-xxxxxxxx |
(4-xxxxxxxxx)-(1-(xxxxxxxxxxxxx)-4-xxxxxxx-4-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
Xxxxxxxxxxx |
1-[4-(3-xxxxxxx xxxxx)-1 -xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
||
Xxxxxx |
X xxxxxxxx xxxxxx pro xxxxxxx použití xxxxxxx x seznamu x.&xxxx;1 |
||
Xxxxxxxxxxxxxxxx |
(2X)-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2-xxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxxxxxx |
x-xxxxxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-xxxxxxxx |
|
2-Xxxxxx-XX-237 |
2-xxxxxx-xxxxxxxxxx |
1-[2-xxxxxx-4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xx]xxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxx-X-47700 |
3,4-XXX-X-47700; 3,4-XXX-47700; XXX-47; XXX-47700 |
X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxx[x][1,3]xxxxxx-5-xxxxxxxxxx |
|
α-Xxxxxxxxxxxxxx butanamid xxxxxx |
XX; X-X |
2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
3 -XxxxxXxxxxxxxXxxxxxxxx |
β'-xxxxxXxxxxxxxXxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-3-xxxxxxxxx-2-xxxxxx |
|
Xxxxxxxxxxxxxx |
X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
Xxxxxxxxxxx |
X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]-5-xxxxxxxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
Xxxxxxxxxxxxx |
2-(4-xxxxxxxxxxxxx)-5-xxxxx-1-(2-(xxxxxxxxxx-1-xx)xxxxx)-1X-xxxxx[x]xxxxxxxx |
||
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
||
X-xxxxxxxxxxxxxxxxxx |
2-[2-[(4-xxxxxxxxxxx)xxxxxx]-5-xxxxx-xxxxxxxxxxxx-1-xx]-X-xxxxx-xxxxxxxxx |
||
X-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-2-[2-[(4-xxxxxxxxxxxxxxx)xxxxxx]-5-xxxxx-xxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
X-xxxxxx X-47931X |
X-xxxxxxxxxxxxxxxx |
4-xxxx-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx 2-xxxxxxxxxxx-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
||
X-XXXX; xxxxxxxxxxxxxxxxxxxxxxxx |
3-(4-xxxxxx-1-xxxxxxxxxxxxxxx-4-xx)xxxxx xxxxxx |
||
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxxx, XXX, 127X49 |
1-(4,4-xx(xxxxxxx-2-xx)xxx-3-xx-2-xx)xxxxxxxxx |
|
Xxxxxxxxxxxx |
X,X-xxxxxxx-5-xxxxx-2-[(4-xxxxxxxxxxxx)xxxxxx]-1-X-xxxxxxxxxxxx-1-xxxxxxxxx |
||
Xxxxxxxxxxxxxx |
5-xxxxx-2-[(4-xxxxxxxxxxxxx)xxxxxx]-1-(2-xxxxxxxxxx-1-xxxxxxx)xxxxxxxxxxxxx |
||
Xxxxxxxxxx z konopí |
|||
Tetrahydrofuranfentanyl |
THF-F |
N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid |
|
Tetramethylcyklopropanfentanyl |
TMCP-fentanyl; XXXX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-1- xxxxxxxxxx |
|
Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxx fentanyl |
N-(1-fenethylpiperidin-4-yl)-N-fenylthiofen-2-karboxamid |
|
4-(Trifluormethyl) X-47700 |
X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxx-4-(xxxxxxxxxxxxxx)xxxxxxxx |
||
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-48800 |
2-(2,4-xxxxxxxxxxxx)-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
||
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-50488 |
3,4-xxxxxxx-X-xxxxxx-X-[2-(1-xxxxxxxxxxxx)xxxxxxxxxx] xxxxxxxxxxxxxx |
||
X-51754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
XxxxxxXxxxxxxxx |
XXX, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; xxxxxxxx xxxxxxxxxx analog |
Včetně xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx všech xxxxxxxxx, xxx xxxx soli xxxxx existovat.
Xxxxxxx x. 4 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 4 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný xxxxx (XXX) |
Další xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx obecný xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
1-(Xxxxxxxxxxxxxxxx)-2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-1X-xxxxxxxxxxxx-5-xxxxxxxxxx |
|||
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
1-(2-(Xxxxxxxxxxx)xxxxxxxxx)xxxxxxxx |
XXXXX |
2-(xxxxxxxxxxx)-1-(xxxxxxxx-1-xx)xxxxxx-1-xx |
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
1-Xxxxxxx |
1-xxxxxxxxx |
1-xxxxxxxx-1-xx-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
1x-XXX, 1X-XXX |
xxxxxxxxxxx xxxxxxxx 1-xxxxxxxxx xxxxxxxxx; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx- -6,6x,8,9-xxxxxxxxxxxxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
2,3-Xxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(2,3-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2,3-Xxxxxxxxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(1,3-xxxxxxxxxxx-4-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2,4,5-Xxxxxxxxxxxxxxxxxxxxx |
2,4,5-XXXX |
||
2,4,6-Xxxxxxxxxxxxxxxxxxx |
XXX-6 |
1-(2,4,6-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,4-Xxxxxxxxxxxxxxxxxxx |
2,4-XXXX |
1-(2,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2,4-Xxxxxxxxxxxxxxxxxxx |
2,4-XXXX |
1-(2,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2',4'-Xxxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
2,4-XXXXX |
1-(2,4-xxxxxxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxxxx |
XXX |
1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxx |
XXX |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
25X-XXXXx |
2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
Xxxxx-36 |
|
25X-XXXXx |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
2X-X-XXXXx |
|
25X-XXX; 25I-NB2F; 2X-X-XXX, XXX-2X-X; Xxxxx-21 |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
25X-XXXX |
2-{[2-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxx |
2X-X-XXXX; Xxxxx-27 |
|
251-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2X-X-XXX |
2X-X-XXX |
2-(4-xxxx-2,3,6,7-xxxxxxxxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxxxxx |
|
2X-X |
2X-X |
2,5-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxx |
XX-25 |
2X-X |
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxxxxx |
2-Xx-2'-Xxx-XXX, |
2-(2-xxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX; 2-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2X-XXXXX; XXX-13 |
8-xxxxxxxxxx-3-[(4,4-xxxxxxφxxxxxxxx-1-xx)xxxxxxxx]-4-xxxxxxxxxxxxx |
||
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2-XXXX |
1-(xxxxxxxxxx-2-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
2-Xxxxxxxxxxxxxxx |
X-xxxxxx-xx-XXXX-2 |
1-(6-xxxxxxx-1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
2-XXXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
2-XXXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)-xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
2-Xxxxxxxxxx-3-xxxxxxx-xxxxxxxxxxx |
α-XXX-XxX; XXxXXX |
3-xxxxxxx-1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
3-(4-Xxxxxxxxxxxxxxxxxxxx)-1-xxxxxxxxxxx |
Xxx Xxxx |
[4-(xxxxxxxxxxxxx)xxxxx]-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
|
3-(x-Xxxxxxxxxxxxxx)-X-xxxxxxxxxxx |
(4-xxxxxxxxxxxx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
3',4'- Xxxxxxxxxxxxx-α-xxxxxx XXX |
XXXXX |
1-(3,4-xxxxxxxxxxxxxxxxxx)-2-xxxxxx-2-xxxxxxxxxxxxxxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxx |
3,4-XXXX; |
1-(3,4-xxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
xxxxxx (2X)-2-(3,4-xxxxxxxxxxxx)-2-[(2X)-xxxxxxxx-2-xx]xxxxxx |
|
3,4-Xxxxxxx-X,X-xxxxxxxxxxxxxxxxxxxx-xxxxxxxx |
3,4-XXXXXXX |
2-(xxxxxxxxxxxxxxxxxxxxx)-1-(3,4-xxxxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxx-α-XXX |
3,4-XXxX-α-XXX |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
3,4-XXxX-α-XXX |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
XXXX |
3',4'-Xxxxxxxxxxxxx-α-xxxxxxxxxxxxxxxx-xxxxx |
XXXXX |
(XX)-1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx |
|
3 ',4'-Xxxxxxxxxxxxx-α-XXX |
XXXXX |
1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
3 -Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-2-xxxxxxxxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|
3X-Xxxxxxxxxxx |
3-XXX; PAL-593 |
2-(3-fluorofenyl)-3-methylmorfolin |
|
3-Fluoramfetamin |
3-FA |
1-(3-fluorfenyl)propan-2-amin |
|
3-Fluorethamfetamin |
3-FEA; 3-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-2-xxxx; X-xxxxx-3-xxxxxxxxxxxxxx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxx-α-XXX |
3X-α-XXX; 3F-PVP |
1-(3-fluorfenyl)-2-(1-pyrrolidin)pentan-1-on |
3-Fluor-α-PVP |
3-Hydroxyfenazepam |
3-HOP, XXXX, 3-xxxxxxxxxxxx, 3 -xx xxxxx xxxxxxxxx |
7-xxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XX-XXX; |
3-[1-(xxxxxxxxx-1-xx)xxxxxxxxxx] xxxxx |
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
3-Xxxxxxx eticyklidin |
3-MeO-PCE |
N-ethyl-1-(3-methoxyfenyl)cyklohexan-1-amin |
|
3-Methoxy fencyklidin |
3-MeO-PCP |
1-[1-(3-methoxyfenyl)cyklohexyl]piperidin |
|
3-Methoxymethkathinon |
3-MeOMC |
1-(3-methoxyfenyl)-2-(methylamino)propan-1-on |
|
3-Methyl-4-fluormethkathinon |
3-Methylflefedron |
1-(4-fluor-3-methylfenyl)-2-(methylamino)propan-1-on |
|
3-Methylamfetamin |
3-MA |
(2RS)-1-(3-methylfenyl)propan-2-amin |
|
3-Methylethkathinon |
3-MEC |
2-(ethylamino)-1-(3-methylfenyl)propan-1-on |
|
3-Methylmetamfetamin |
3-MMA |
1-(3-methylfenyl)-N-methylpropan-2-amin |
|
3-Methylmetkathinon |
3-MMC |
2-(methylamino)-1-(3-methylfenyl)propan-1-on |
|
3-Methyl-N,N-dimethylkathinon |
3-MDMC |
1-(3-methylfenyl)-2-(dimethylamino)propan-1-on |
|
3-Methyl-N-ethylnorpentedron |
3-MEAP |
2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on |
|
3-Methylthioamfetamin |
3-MTA |
(2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin |
|
4'-Fluor-4-methylaminorex |
4-FPO; x-X-4-xxxxxxxxxxxxxx |
5-(4-xxxxxxxxxx)-4,5-xxxxxxx-4-xxxxxx-2-xxxxxxxxxx |
|
4'-Xxxxxx-X-xxxxxxxxxxxxxxxxxx |
4'-xxxxxx-XxXX |
1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxx-1-xx)xxxxx-1-xx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XxXX |
4-xxxxxx-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XXX; XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
4'-Xxxxx-α-XXX |
4'-xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
|
4-Xxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
4-Xxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4Xx-α-XXX |
1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
4-Xxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4Xx-α-XXX; xXXXX, 4Xx-XXX |
1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4X-XXX; x-xxxxxxxxxxxxxxxxxxxx |
xxxxx-2-(4-xxxxxxxxxx)-2-(2-xxxxxxxxx)xxxxxx |
|
4-Xxxxxxxxxxxxx |
4-XX |
2-xxxxx-1-(4-xxxxxxxxxx)-xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
4X-XXX; 4-FMPH |
Methyl-2-(4-fluorfenyl)-2-(2-pipendyl)acetát |
4F-TMP |
|
4-Fluor-N-ethylbufedron |
4F-NEB |
2-(ethylamino)-1-(4-fluorfenyl)butan-1-on |
|
4-Fluor-N-ethylpentedron |
4F-NEP; 4-xxxxx-α-xxxxxxxxxx-xxxxxxxxxxx |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-X-xxxxxxxxxxxxxxxxxxxxx |
4X-XXX; 4X-XXX; 4X-XXXX |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxx |
4-XXX; 4-X-xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxx-α-XXX; 4X-XXX; O-2370 |
1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
4-Fluor-α-pyrrolidinbutiofenon |
4F-PBP |
1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)butan-1-on |
|
4-Fluor-α-pyrrolidinenanthofenon |
4F-α-PEP; 4X-XX8 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-X-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4X-xxxxx-XXxX; 4X-α-XxXX |
1-(4-xxxxxxxxxx)-4-xxxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4X-α-XXX; 4F-PV9 |
1-(4-fluorfenyl)-2-(pyrrolidin-1-yl)oktan-1-on |
|
4F-MDMB-BICA |
methyl (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
4X-XXXX-XXXXXX; 4X-XXX |
xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
4-X-α-XXX xxxxxxxxx xxxxxx |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxx)xxxxxx-1-xx |
||
4-XXXXXXX |
4-xxxxxxx-3,3,4-xxxxxxxxx-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxx-1-xx |
||
4-Xxxxxxx-X-xxxxxx-X-xxxxx tryptamin |
4-HO-MET |
3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol |
Metocin; Xxxxxxxxxxx |
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-Xx-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
4-Xxxxxxxxxxxxx |
Xx5-4864, chlorodiazepam |
7-chlor-5-(4-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
|
4-Chlorethkathinon |
4-CEC |
1-(4-chlorfenyl)-2-(ethylamino)propan-1-on |
|
4-Chlorisopropylkathinon |
4-CIC; xxxxxxxxxxx, |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX \ |
4-Chlormethkathinon |
4-CMC |
1-(4-chlorfenyl)-2-(methylamino)propan-1-on |
Clefedron |
4-Chlor-N,N-dimethylkathinon |
4-CDC; 4-XXXX |
1-(4-xxxxxxxxxx)-2-(X,X-xxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-X-xxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
4-Xxxxxxxxxxxxxxxxxx |
4-Xxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxx-α-XXX |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
4-XXXX |
4-XXXX |
1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX; 4-XXXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX; 4-XxX-α-XX8 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxxx α-POP; 4-XxX-α-XX9 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4'-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-Xxxxxxx-α-XXX; XXXXX |
(XX)-1-(4-xxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
4-XX |
|||
4-Xxxxxxxxxxxxxx |
4-Xx-XXXX |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxx |
Xxxxxxxxxxx; 4-XX |
2-xxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxx |
2-xxxxxxxxxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-xxxxxx-X-xxxxxxxxxxxxxx |
(4-XXX) |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx |
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
5 - Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
5-XXXx; indanyl-α-PHP |
1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on |
||
5C-AKB48; 5X-XXXXXXX |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
5Xx-XX-XXXXXX |
X-[(2X)-1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx]-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
5Xx-XXXX-XXXXXX; 5Xx-XXX |
xxxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
5-Xx-xxxxxx XXX 018 xxxxxxx xxxxxx |
5Xx-XXX-018; 5Xx-XXX-018-X, XXX-018 xxxxxx xxxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
|
5 -Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; XXXX |
1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
5X-3,5-XX-XXXXXXXX; 5F-3,5-AB-FUPPYCA, XX-037 |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx |
||
5X-5,3-XX-XXXXXXXX; 5X-XX-XXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-5-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XX-X7XXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
5X-XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX57 |
xxxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXX |
xxxxxx (2S)-2-[[1-(5-fluorpentyl)indol-3-karbonyl]amino]-3-methylbutanoát |
||
5F-AMB-PINACA; 5X-XXX |
xxxxxx-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
5X-XXX |
|
5X-X-X7XXXX |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXX |
X-(1-xxxxx-1-xxx-3-xxxxxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
5X-XXXXX-XXXXXXXXX |
5-(5-xxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxxxxxxx)-xxxxxx[4,3-x]xxxxx-1-xx |
||
5X-XXXX-XXXXXX |
xxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
5X-XXX-XXXXXX |
xxxxx 2-[[1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
||
5X-XXX-398; XX-2201; |
(4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-xxxxxxxx |
||
5X-XXXX-X7XXXX |
xxxxxx-2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xx]xxxxxxxxx}-3,3-xxxxxxxx xxxxxxxx |
||
5X-XXXX-XXXX; |
xxxxxx (S)-2-({[1-(5-fluorpentyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
||
5F-MDMB-PINACA; 5X-XXX |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
5X-XXXX-2 |
1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XX-22 indazol xxxxxx |
xxxxxxxx-8-xx 1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XX-22; 5X-XXXXX |
8-xxxxxxxxxx xxxxx xxxxxxxx 1-(5-fluorpentyl)-1H-indol-3-karboxylové |
||
5-F-pentyl-3-pyridinoylindol |
[1-(5-fluorpentyl)-1H-indol-3-yl] (pyridin-3-yl)methanon |
||
5F-PY-PICA |
1-(5-fluorpentyl)-3-(pyrrolidin-1-karbonyl)-1-H-indol |
||
5F-PY-PINACA |
[1-(5-fluorpentyl)indazol-3-yl]-pyrrolidin-1-yl-methanon |
||
5F-SDB-005 |
naftalen-1-yl-1-(5-fluorpentyl)-1H-indazol-3-karboxylát |
||
5F-SDB-006 |
N-benzyl-1-(5-fluorpentyl)-l X-xxxxx-3-xxxxxxxxxx |
||
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
5-XxX-XXX |
5 -methoxy-α-methyltryptamin |
||
5-MeO-DALT |
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amin |
||
5-MeO-MiPT |
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amin; 5-xxxxxxx-X-xxxxxx-X-xxx-xxxxxx xxxxxxxxx |
||
5-Xxxxxxxxxxxx Ion |
N-methyl-bk-MMDA-5 |
1-(7-methoxybenzo[d] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
5-XXXx |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
6-XXX |
6-(2-xxxxxxxxxxx)xxxxxxxxxx |
||
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
X-796,260 |
[1-(2-xxxxxxxx-4-xxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
X-796,260 izomer |
((E)-1-(1-(2-morfolm-1-yl)ethyl)indol-3-yl)-3,4,4-tnmethylpent-2-en-1-on |
||
A-834,735 |
1-(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon |
||
A-836,339 |
N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-yliden]-2,2,3,3-tetramethylcyklopropan-karboxamid |
||
AB-005 |
[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)-methanon |
||
AB-005 azepan xxxxxx |
(1-(1-xxxxxxxxxxxx-2-xx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-[(2-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXXXXXX; |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx |
||
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-x(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(2-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxx-XXXXXXXX |
X-(1-xxxxxxxxx)-1-(xxxxxxx xxxxxxxx-4-xxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx-xxxx |
||
XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-\X- xxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxxx |
X 41123 |
1-(8-chlor-6-fenyl-4H-[1,2,4]tnazolo[4,5-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethan xxxx |
|
X-XXXXXXXX |
X-(1-xxxxxxxxx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-57 |
Xxxxxxx-1-xx-1-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
Xxxxxxxxxx triazolbenzofenon derivát |
(2-(3-(aminomethyl)-5-methyl-4-H-1,2,4-triazol-4-yl)-5-chlorfenyl)(fenyl)methanon |
||
AM-1220 |
1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naftyl)-methanon |
||
AM-1220 xxxxxx xxxxxx |
1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx] (xxxxxx)xxxxxxxx |
||
XX-1248 |
xxxxxxx-1-xx(1-((1-xxxxxxxxxxxxxxx-2-xx)xxxxxx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XX-1248 xxxxxx xxxxxx |
xxxxxxx-1-xx(1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
XX-2201 xxxxxxxxxxxx analog; XXXXXXXX |
(1-(5-xxxxxxxxxxx)-1X-xxxxx[x]xxxxxxxx-2-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XX-2201 xxxxxxx xxxxxxxxxx xxxxxx |
X-1-xxxxxxxxxx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-2232 |
5-[3-(1-xxxxxxx)-1X-xxxxx-1-xx]xxxxxxxxxxxx |
||
XX-2233 |
1-[(X-xxxxxxxxxxxxxxx-2-xx)xxxxxx]-3-(2-xxxxxxxxxx)xxxxx |
||
XX-6527 |
1-xxxxxx-X-(xxxxxxxx-1-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XX-6527 5-xxxxxxxxxxx xxxxxxx |
1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-1-xx)-1X-xxxxx-3-xxxxxxxxx |
||
XX-679 |
(2-xxxxxxxx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XX-694 |
1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx |
||
XX-694 (ethyl xxxxxxxxx xxx) |
1-(5-xxxxxxxxxxx)-3-(2-xxxxxxxxxxxx)xxxxx |
||
XX-694 (xxxxxx xxxxxxxxx xxx) |
1-(5-xxxxxxxxxxx)-3-(2-xxxxxxxxxxxxx)xxxxx |
||
XX-694 xxxxx xxxxxxx |
1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx |
||
XXX-4xx-XXXX |
xxxxxx-3-xxxxxx-2-[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xxxxxxxxxxx]xxxxxxxx |
||
XXX-XXXXXX |
xxxxxx 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xxxxxxxxxx]-3-xxxxxxxxxxxxxx |
||
XXX-XXXXXXXX; XXX-XXX |
Xxxxxx 2-({1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
XXX-XXXXXXXX |
|
XXX-XXXXXX |
Xxxxxx (2S)-2-{[1-(cyklohexylmethyl)indol-3-karbonyl]amino}-3-methylbutanoát |
||
AMB-CHMrNACA |
methyl 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamid)-3-methylbutanoát |
||
APICA; XXX-001, 2XX1 |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
XXX48 |
|
XXX-XXXXXX |
X-(1-xxxxx-1-xxx-3-xxxxxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-(xxxxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
xx-2X-X; βx-2X-X |
2-xxxxx-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xx |
||
xx-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
||
xx-XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxx-1-xx |
||
XXXX; 3,4-XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxx |
8-xxxx-6-xxxxx-1-xxxxxx-4X-xxxxx[x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
||
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
|
XXX-018 |
xxxxxxxx-1-xx 1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XX 47,497 |
2-[(1S,3R)-3-hydroxycyklohexyll-5-(2-methyloktan-2-yl)fenol |
||
CP 47,497 (C8 + X2) |
2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(2-xxxxxxxxxxx-2-xx)xxxxx; 2-((1S,3R)-3-hydroxycyklohexyl)-5-(dekan-3-yl)-fenol |
1,1-dimethyl x 1-xxxxx xxxxxxx X8-xxxxxxxx |
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
XXXXX-4XX-X7XXXX |
1-(4-xxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-4XX-XXXXXX; XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-5X-X7XXXX |
1-(5-x:xxxφxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-5XXXXX |
1-(5-xxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXX-5XXXXXXX |
|||
XXXXX-XXXX |
1-xxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXX-XX-XXXXXXXXX |
5-(xxxxxxxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxx-xxxxx)xxxxxx[4,3-x]xxxxx-1-xx |
||
XXXXX-XXXXXXXXX; XXX-151 |
2-(1-xxxxxx-1-xxxxxxxxxx)-5-xxxxxx-xxxxxx[4,3-x]xxxxx-1-xx |
||
XXXXX-XXXX |
1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXX-XXXXXX |
1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-XXXXXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1-((xxxxxxxxxx-2X-xxxxx-4-xx)xxxxxx)-1-X-xxxxxxx-3-xxxxxxxxxx |
||
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxxx |
XXX-2; etizolam-2 |
2-ethyl-9-methyl-4-fenyl-6H-thieno[3,2-f][1,2,4]tnazolo[4,3-a][1,4]diazepin |
|
Deschlorketamin |
2-(methylamino)-2-fenylcyklohexan-1-on |
||
Deschlor-N-ethyl-ketamin |
O-PCE; 2-Xxx-XXX, eticyclidone |
2-(ethylamino)-2-fenylcyklohexan-1-on |
|
Dibutylon |
Bk-DMBDB |
1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-butanon |
Methylbutylon |
Diclazepam |
2-chlorodiazepam |
7-chlor-5-(2-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
Ro 5-3448 |
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx] xxxx |
|
Xxxxxxxxx |
XXX; 1,2-XXX; XXXX |
1-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
XX1X4X21 |
Xxxxxxxxxxxxx |
Xx 07-4065 |
7-xxxxx-5-(2,6-xxxxxxxxxxxx)-1-xxxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx |
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XX-4662 |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
|
Xxxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
3,4-xxxxxxxxxxxxxxx- methylkathinon |
Dimethyltriptamin |
DMT |
N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin |
|
Dipentylon |
2-(dimethylamino)-3΄,4΄-(methylendioxy)valerophenone |
1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-pentan-1-on |
|
DMBA-CHMINACA |
2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamido)-3,3-dimethylbutanová xxxxxxxx |
||
XXX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(4-xxxxx-xxxxxxxx-1-xx)xxxxxxxx |
||
Xxxxxxxx |
XXXXX; xxxxxxxxxx; XXX |
X-xxxxx-1,2-xxxxxxxxxxxxxxxx |
|
XX-018 |
xxxxxxxx-1-xx(9-xxxxxx-9X-xxxxxxxx-3-xx)xxxxxxxx |
||
XX-2201 |
(9-(5-xxxxxxxxxxx)-9X-xxxxxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-XXXXXXXX |
Xxxxx 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
||
Xxxxxxx |
XXXXX; xx-XXXX |
1-(xxxxx[x] [1,3]dioxol-5-yl)-2-(ethylamino)pentan-1-on |
N-ethyl-pentylon |
Ethkathinon |
Ethylpropion; X-xxxxxxxxxxxxxx; ETH-CAT |
2-ethylamino-1-fenyl-propan-1-on |
|
ETH-LAD |
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindo1-[4,3-fg]chinolin-9-karboxamid |
||
Ethylfenidát |
(RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
Ethylon |
bk-MDEA |
2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on |
|
Ethyltenamfetamin |
MDE, MDEA |
(2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
Eticyklidin |
PCE |
N-ethyl-1-fenylcyklohexylamin |
|
Etizolam |
AHR3219; Xxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-9-xxxxxx-67/-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
Xxxxxxx |
xx-XXXX, N-Ethylbutylone |
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-on |
|
FDU-PB-22 |
1-naftyl 1-[(4-fluorfenyl)methyl]indol-3-karboxylát |
||
Fenibut |
phenibut |
4-amino-3-fenylbutanová xxxxxxxx |
|
Xxxxxxxxxxxxx |
Xx 11-5073/000 |
8-chlor-6-(2-fluorfenyl)-1-methyl -4H- [1,2,4]xxxxxxx[4,3-x] [1,4]benzodiazepin |
|
Flubromazepam |
7-brom-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Flubromazolam |
8-brom-6-(2-fluorfenyl)-1-methyl-4H-[1,2,4]tnazolo-[4,3a] [1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
2-xxxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x] [1,2,4]xxxxxxx[4,3-x] [1,4] xxxxxxxx |
||
Xxxxxxxxxxxxx |
6-(2-xxxxxxxxxx)-1-xxxxxx-8-xxxx-4X-[1,2,4]xxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxx |
Xx 05-4435 |
5-(2-xxxxxxxxxx)-1,3-xxxxxxx-7-xxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|
XXX-144 |
[1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XXX-XXX48 |
X-((3x,5x,7x)-xxxxxxxxx-1-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXX-018 |
(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-XXX-22 |
xxxxxxxx-8-x1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XX-22 |
xxxxxxxx-8-xx-1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
Xxxxxxxx |
β-xxxxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
Xxxxxxx |
βx-XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
|
XX-210 |
(6xX, 10xX)-9-(xxxxxxxxxxxxx)-6,6-xxxxxxxx-3-(2-xxxxxxxxxxx-2-xx)-6x,7,10,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
||
XX-331 |
3X,4X-x-xxxxxxxxxxx-3-xxxxxxx-2-x-xxxxxx-(1,8)-xxxx-3-xx-5-xxxxxx |
||
Xxxxxxxxxxxxxxxxxxx |
(2X,X)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxx |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-xxxxx-2-(xxxxxxxxxx-1-xx)-xxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxxxx)xxxx |
|
Xxxxxxxxxxx |
4-xxxxxx-2-(xxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxx |
XXXX |
xxxxxxxxx2-xxxxx-2-(2-xxxxxxxxx)xxxxxx |
|
XXX-907 |
X-(Xxxxx[1,3]xxxxxx-5-xxxxxxxx)-7-xxxxxxx-2-xxx-8-xxxxxxxxx-1,2-xxxxxxxxxxxxxxx-3-xxxxxxxxxx |
||
XXX 018 X-5-xxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX 018 X-5-xxxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-007 |
1-xxxxxx-2-xxxxxx-3-(1-xxxxxxx)xxxxx |
||
XXX-018 |
(xxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-018 xxxxxxxxxx xxxxxxx; |
1-xxxxxx-3-(xxxxxxx-1-xxx)xxxxx |
||
XXX-018 xxxxxxxxxxxxxxx xxxxxxx |
[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (naftalen-1-yl)methanon |
||
JWH-018 |
xxxxxxxx-8-xx-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-018 xxxxxxx xxxxxx |
1-xxxxxxxxxx(1-xxxxxx-1X-xxxxxxx-3-xx)-xxxxxxxx |
||
XXX-019 |
1-xxxxx-3-(1-xxxxxxx)xxxxx |
||
XXX-022 |
xxxxxxxx-1-xx(2-(xxxx-4-xxxx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-030 |
xxxxxxxx-1-xx(1-xxxxxx-1X-xxxxxx-3-xx)xxxxxxxx |
||
XXX-071 |
(1-xxxxx-1X-xxxxx-3-xx)-1-xxxxxxxxx 1-methanon |
||
JWH-073 |
(1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon |
||
JWH-073 xxxxxx xxxxxxx |
1-xxxxx-3-(1-(4-xxxxxx)xxxxxxx)xxxxx) |
||
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 xxxxxxxx 2-xxxxxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxxx-1-xx)(2-xxxxxx 1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 xxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxxx-1-xx)(1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-145 |
xxxxxxxx-1-xx(1-xxxxxx-5-xxxxx-1X-xxxxxx-3-xx)xxxxxxxx |
||
XXX-182 |
1-xxxxxx-3-(4-xxxxxx-1-xxxxxxx)xxxxx |
||
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-203 |
2-(2-xxxxxxxxxx)-1-(1-xxxxxxxxxxx-3-xx)xxxxxxx |
||
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
XXX-2501 2-xxxxxxxx-X-xxxxxx-xxxxxxxxx derivát |
1-(2-methylen-N-methylpiperidyl)-3-(2-methoxyfenylacetyl)indol |
||
JWH-251 |
2-(2-methylfenyl)-1-(1-pentyl-1H-indol-3-yl)methanon |
||
JWH-302 |
1-pentyl-3-(3-methoxyfenylacetyl)indol |
||
JWH-307 |
(5-(2-fluorfenyl)-1-pentylpyrrol-3-yl)-naftalen-1-ylmethanon |
||
JWH-307 brom xxxxxxx |
(5-(2-xxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-368 |
[5-(3-xxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
XXX-370 |
[5-(2-xxxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
XXX-387 |
1-xxxxxx-3-(4-xxxx-1-xxxxxxx)xxxxx |
||
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-412 |
|||
XXX-412 5-xxxxxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx |
||
XXX-xxxxxxxxxxxxxxxx-8-xxxxxxxxxx; XX-22 |
xxxxxxxx-8-xx 1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
Xxxxxxxxxxxxx |
xxxxxxxxxx; BRN 4550445 |
8-xxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-1-xxxxxx-8-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-(xxxxxxxxxxxxxxxxx)-7-xxxx-1,3-xxxxxxx-2X-[1,4]-xxxxxxxxxxxxx-2-xx |
||
XXX-701 |
1-(5-xxxxxxxxxxx)-X-xxxxx-xxxxx-3-xxxxxxxxxx |
||
XX2183240 |
X,X-xxxxxxxx-5-[(4-xxxxxxx)xxxxxx]xxxxxxxx-1-xxxxxxxxxx |
||
X5XXXX |
xxxxxx-1-(5-xxxxxxxxxxx)-1X-xxxxx-xxxxxxxxxx |
||
XXX-2201 |
1-(5-xxxxxxxxxxx)-3-(4-xxxxxx-xxxxxxx)xxxxx |
||
XXX-2201 xxxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](4-xxxxxx-xxxxxxxx-1-xx)-xxxxxxxx |
||
XXX-XXXXXXXX |
2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx kyselina |
||
MBZP |
1 -xxxxxx-4-xxxxxxxxxxxxxxx |
||
XXX 19 |
X-[(X)-(1-xxxxx-2-xxxxxxxx-3-xxxxxx)xxxxx]xxxxxxxx |
||
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
XXXX-4xx-XXXXXX |
(xxxxxx 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido) butanoát) |
||
MDMB-FUBICA |
methyl 2-(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
XXXX-XXXXXXX |
xxxxxx 2-(9-(xxxxxxxxxxxxxxxx)-9X-xxxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
XXXX-XXXXXX |
X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx-xxxxx, methyl xxxxx |
||
XXXX-XXXXX |
xxxxxx 3,3-xxxxxxxx-2-(9-xxxxxx-9 H-karbazol-3-karboxamido)butanoát |
||
MDPHP; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
Xxxxxxxxxxxx |
(X)-5-(2-xxxxxxxxxx)-3-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
(4-xxxxxxxxxxxxxxx-1-xx)-(1-xxxxxxxxxxx-3-xx)xxxxxxxx |
||
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxx, Dimethylpropion |
2-dimethylamino-1-fenylpropan-1-on |
|
Methamnetamin |
methylnaphetamine, |
X-xxxxxx-1-(xxxxxxxx-2-xx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxx |
X-(2-xxxxxxx-xX-xxxxxxxxxxx)-5X,8X,11X,14X-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
Xxxxxxxxxxxxxx |
XXXx, 2-Oxo-3'-methoxy-PCPr |
2-(3-methoxyfenyl)-2-(propylamino)cyklohexan-1-on |
|
Methoxyamfetamin |
PMA |
(2RS)-1-(4-methoxyfenyl)propan-2-amin |
|
Methoxymetamfetamin |
PMMA |
1-(4-methoxyfenyl)-N-methylpropan-2-amin |
|
Methoxytenamfetamin |
MMDA |
(2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin |
|
Methylaminorex |
(±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin |
||
Methylklonazepam |
ID 690; XX-690; methylclonazepam; Xx 05-4082; Xx 5-4082 |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx |
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2X,X)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
Xxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
Xxxxxxxx |
4-XXX-xXx; XXX |
(3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
X-XXXXX |
1-(xxxxxxxxxxxxxxxx)-2-xxxxxx-xxxxx-3-xxxxxxxxxx |
||
XX-18 |
X-(xxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXXXX |
1-xxxxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx 1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXxX-2201 |
xxxxxx 2-{[1-(5-fluorpentyl)-1H-indol-3-yl]formamido}-3-fenylpropanoát |
||
N-(2-methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamin |
|||
N,N-diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamin |
|||
Naftylpyrovaleron |
Nafyron |
1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on |
O-2482 |
N-butylhexedron |
N-butylnorhexedrone, XXX |
2-(xxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxx |
xxxxx-xxxxxxxxx, xxxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxx, XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
XXX-xxxxx xxxxxx |
xx-XXX; , xx-XXXXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|
X-xxxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
|
X-xxxxxxxxxxxxx |
XXX-XX; Xxxxxxxxxxxxxx; Xxxxx-Xxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxx-1-xx |
|
X-xxxxx-xxxxxxxxxxx |
XXxX |
2-(xxxxxxxxxx)-4-xxxxxx-1-xxxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
α-xxxxxxxxxxxxxxxxxx-xxx |
Xxxxxxxxx |
5-(2-xxxxxxxxxx)-3-xxxxxxx-7-xxxxx-1X-xxxxx[x][1,4]xxxxxxxx-2(3X)-xx |
||
X-xxxxxxxxxxxxxxxxx |
XxXX; N-isopropylhexedron |
2-(isopropylamino)-1-fenylhexan-1-on |
|
N-isopropylpentedron |
NiPP; XXX, 2-XXX |
2-(xxxxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
|
Xxxxxxxxxx |
1-xxxxxx-8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
||
XX-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
X-xxxxxx-2-xxxxxxxxxx |
X-xxxxxx-2XX |
2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx |
XX-2XX |
X-xxxxxxxxxxxxxxx |
2-[xxxxxx(xxxxxx)xxxxx]-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxxx, desalkyl-flurazepam, xxxxxxxxxxxxx, Xx 5-3367 |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-2-xx |
|
X-xxxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx }xxxxxx |
Xxxxxxxxxx |
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
Xxx 27569 |
5-xxxxx-3-xxxxx-X-{2-[4-(1-xxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx |
||
Xxx 27759 |
5-xxxxx-3-xxxxx-X-{2-[4-(xxxxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx |
||
Xxx 29647 |
5-chlor-3-ethyl-N-(1-benzylpyrrolidin-3-yl)-3H-indol-2-karboxamid |
||
Parahexyl |
3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol |
||
PB-22 xxxxxxx xxxxxx |
xxxxxxxx-8-xx-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxxxxx; βk-MBDP |
(±)-1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-on |
|
p-Fluorfenylpiperazin |
pFPP |
1-(4-fluorfenyl)piperazin |
|
p-Methyl-4-methylaminorex |
4,4'-DMAR |
4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin |
p4-DMAR |
Pravadolin |
WIN 48,098 |
(4-xxxxxxxxxxxx)-[2-xxxxxx-1-(2-xxxxxxxx-4-xxxxxxx)xxxxx-3-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxx; XX |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxx |
X-xxxxxxxxxxxxxxxxxx; |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
XX8, α-PHPP |
1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
XX9, α-POP |
1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
Xxxxxxxxx |
8-xxxx-1-xxxxxx-6-(xxxxxxx-2-xx)-4X-[1,2,4]xxxxxxxx[4,3 -x] [1,4]xxxxxxxxxxxxx |
||
XXX-4 |
(4-xxxxxxxxxxxx)(x -pentyl-1H-indol-3-yl)methanon |
||
RCS-4 xxxxx xxxxxx |
(2-xxxxxxxxxxxx)(x -pentyl-1H-indol-3-yl)methanon |
||
RCS-4(C4) |
4-methoxyfeny1-(1-butyl-1H-indol-3-yl)methanon |
||
Rolicyklidin |
PHP, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] xxxxxxxxxx-7-xxxxxxxxxx |
||
XXX-005 |
xxxxxxxx-1-xx-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-006 |
X-xxxxxx-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-006 X-xxxxx analog |
1-pentyl-N-fenyl-1H-indol-3-karboxamid |
||
STS-135 |
N-(1-adamantyl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid |
||
Tenamfetamin |
MDA |
(2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
Tenocyklidin |
TCP |
1-[1-(2-thienyl)cyklohexyl]piperidin |
|
Tertylon |
tBuONE; MDPT |
1-(1,3-benzodioxol-5-yl)-2-(tert-butylamino)propan-1-on |
|
Tetrahydrokanabinol |
THC |
Δ6a(10a)-, Δ6α(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-xxxxxxxxxxxxxxxxxxxx x xxxxxx xxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xxxxx |
||
XXX-2201 |
5X-XXX-018-X, |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx] (1 -xxxxxx)xxxxxxxx |
|
XX-XXX; 3',4'-xxxxxxxxxxxxxx-α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxx-2-xx)xxxxx-1-xx |
||
XX-XXX; 2-xxxxxxxxx-1-xx-1-xxxxxxxx-6-xx- hexan-1-on |
2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)hexan-1-on |
||
TH-PVP |
2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on |
||
trans-CP 47,497-X8 |
5-(1,1-xxxxxxxxxxxxx)-2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-xxxxx |
||
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
XX-144(-2X); |
[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
XX-144xxxxxx xxxxxxx |
(1-xxxxxx-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)-xxxxxxxx |
||
XX-144X-(5-xxxxxxxxxxx) xxxxxxx |
(1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XXX-597 |
[3-(3-xxxxxxxxxxxxxx)xxxxx]-X-xxxxxxxxxxxxxxxxxx |
||
XXX-754 |
6-xxxxxx-2-[(4-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxx-4-xx |
||
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
XXX 55212-2 |
(R)-(+)-[2,3-dihydro-5-methyl-3-(4-morfolinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yljnaftalen-1-ylmethanon |
||
α-PVP |
1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on |
||
α-PVT |
2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on |
||
α-Pyrrolidinohexanofenon |
α-PHP |
1-fenyl-2-(pyrrolidin-1-yl)-1-hexan-1-on |
|
α-Pyrrolidinoisohexanofenon |
α-ΡιΗΡ |
1-fenyl-4-methyl-2-(pyrrolidin-1-yl)-1-pentan-1-on |
|
α-Piperidinbutiofenon |
α-PipBP |
1-fenyl-2-(piperidin-1-yl)butan-1-on |
|
α-Pyrrolidinbutiofenon |
α-PBP |
1-fenyl-2-(pyrrolidin-1-yl)butan-1-on |
|
α-Pyrrolidinbutiothiofenon |
α-PBT |
2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)butan-1-on |
|
α-Pyrrolidinnonafenon |
α-PNP; XX-10; alpha-pyrrolidi-nononaphenone |
1-fenyl-2-(pyrrolidin-1-yl)nonan-1-on |
|
α-Pyrrolidinpropiofenon |
α-PPP |
1-fenyl-2-(pyrrolidin-1-yl)propan-1-on |
|
β-Keto-indanylmethylaminopropan |
bk-IMP |
1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)propan-1-on |
Včetně xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx, xx xx xxxxxxxx xxxxxxx, xxxxxxxxx v xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxx zvláštního xxxxxxxxxx xxxxxxxx, a solí x xxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu xx xxxxx případech, xxx xxxxx xxxxxxxxx.
Xxxxxxx č. 5 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 5 psychotropních xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) amino]heptanová |
||
Buprenofin |
(2S)-2-[(5R,6R,7R,14S)-17-(cyklopropylmethyl)-4,5α-epoxy-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx butan-2-ol |
||
Bromdimethoxyfenethyl amin |
2C-B |
(4-brom-2,5-dimethoxyfenethyl)amin |
|
Dexamfetamin |
(2S)-1-fenylpropan-2-amin |
||
Fencyklidin |
PCP |
1-(1-fenylcyklohexyl)piperidin |
|
Fenetylin |
7-(2-{[(2RS)-1-fenylpropan-2-yl]amino}ethyl)-1,3-dimethyl-7H- xxxxx-2,6-xxxx |
||
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
XXX |
xxxxxxxx 4-hydroxybutanová |
||
Levamfetamin |
(2RS)-1-fenylpropan-2-amin |
||
Levmetamfetamin |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
Lisdexamfetamin | (2S)-2,6-diamino-N-[(2S)-1-fenylpropan-2-yl]hexanamid | ||
Meklochalon |
3-(2-chlorfenyl)-2-methyl-1,2-dihydrochinazolin-4(3H)-on |
||
Metachalon |
2-rnethyl-3-(2-methylfenyl)-1,2-dihydrochinazolin-4(3H)-on |
||
Metamfetamin |
(2S)-1-fenyl-N-methylpropan-2-amin |
||
Metamfetamin racemický |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
Methylfenidát |
methyl-(2RS)-2-fenyl-2-[(2RS)-piperidin-2-yl]acetát |
||
Sekobarbital |
kyselina 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxx xxxxxxxxxxxxx x xxxxxx |
xxxx. (-)-trans-Δ9-THC |
Zipeprol |
(2RS)-1-fenyl-1-methoxy-3-[4-(2-methoxyfenethyl)piperazin-1-yl] propan-2ol |
Včetně xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx všech případech, xxx xxxxxxxxx xxxxxxxx xxxx je xxxxx.
Xxxxxxx x. 6 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 6 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx nebo obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxxxxx 5-allyl-5-isobutylbarbiturová |
||
Cyklobarbital |
kyselina 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxxx | XXX | xxxxxx-2-xx | xxxxx-xxxxxxxxxxxxx |
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
||
Xxxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5[(1XX)-1-xxxxxxxxxxx]xxxxxxxxxxx |
Xxxxxx xxxx xxxxx xxxxxxxxx x této xxxxxxx xx všech xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx je možná.
Xxxxxxx x. 7 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 7 psychotropních xxxxx
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x xxxxxx xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx nebo obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx kyselina |
||
Bentazepam |
CI 718; XX 6008; Xxxxxxxxxx; |
5-xxxxx-1,3,6,7,8,9-xxxxxxxxx-2X-[1]xxxxxxxxxxx[2,3-x] [1,4]xxxxxxxx-2-xx |
|
Xxxxxxxxxxx |
(+)-X-xxxxxx-X-(2-xxxxx-1-xxxxxxxxxx)-X-xxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
1-xxxxxxxxxxxxxxx |
||
Xxxxxxxxxx |
7-xxxx-5-(2-xxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-ƒ][1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxx |
||
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
Cinazepam |
BD-798; |
4-[[7-brom-5-(2-chlorfenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]oxy]-4-oxo-butanová xxxxxxxx |
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx)xxxxxxxx |
||
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxx |
7-Xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxxx |
(+)-1-xxxxx-2-[(2-xxxxxxxxx)xxxxx] xxxxxx |
||
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
XX-xxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
XX-xxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxxxxxxxxxx |
||
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-4,7(6X)-xxxx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxxx-2,4(3X,5X)-xxxx |
||
Xxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X-xxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2.1-α]-xxxxxxxx-5-xx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxxx |
3,3-xxxxxxx-5-xxxxxxxxxxxxxxx-2,4-xxxx |
||
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-xxxxxxx[1,5-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
5-xxxxx-1-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
5-xxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
10-xxxxx-11x-xxxxx-2-xxxxxx-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x] [1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxx |
5-xxxxx-2-xxxxx-1,3-xxxxxxxxxx-4-xx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(xxxx-2-xx-1-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
xxxxxxx(2-xxxxxxxxx)xxxxxxxx |
||
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxx |
(+)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx | Xxxxxxxxx, Xxxxxxxxx, XXXX 341 Xxxxxxxxx, Seriel, XX | 1-(3,4-xxxxxxxxxxxxxx)-5-xxxxx-7,8-xxxxxxxxx-4-xxxxxx-5X-2,3-xxxxxxxxxxxxx | |
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxx[1,2-x]xxxxxxx-3-xxxxxxxx |
Xxxxxx solí xxxxxxxxxxxxxx xxxxx xxxxxxxxx x&xxxx;xxxxx xxxxxxx ve xxxxx xxxxxxxxx, xxx xxxx xxxx mohou xxxxxxxxx.
Xxxxxxx x. 8 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 8 vybraných xxxxxxxxx
Xxxxxxxxx obsahující: |
Podmínky: |
||
1) |
jednu z xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx xxxxxxxxx xxxxx xxxx xxxx xxxxxxx xxxxx (nikoliv xxxx xxxxxxxx) x xxxxxxxx xxxxxx látky |
|
a) |
v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx xxxxx xxxxxxxxxx 100 mg, |
||
b) |
v xxxxxxx xxxxx být xxxxxxxxxxx xxxxx než 2,5 % |
||
2) |
xxxxxxxxx |
x) |
Xxxxxxxx difenoxinu xxxxx xxxxxxxxxx v xxxxx xxxxxxx, tobolce, ampuli, xxxxx, xxxx. x xxxx xxxxxx xxxxx 0,5 xx. |
x) |
Xxxxxxxx atropin-sulfátu xxxx byt xxxxxxx 5 % x xxxxxxxx xxxxxxxxxxxx v xxxxx xxxxxxx, kapsli, xxxxxx, xxxxx, popř. xxxx xxxxxx formě. |
||
3) |
difenoxylát |
a) |
Množství xxxxxxxxxxxx xxxxx xxxxxxxxxx x jedné xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. x xxxx xxxxxx formě 2,5 xx. |
x) |
Xxxxxxxx atropin-sulfátu xxxx xxx nejméně 1 % x xxxxxxxx xxxxxxxxxxxx x jedné xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. v xxxx xxxxxx xxxxx. |
||
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
x) |
xxxxx xxxxxxxxxx 135 xx v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx lékové xxxxx. |
||
x) |
x xxxxxxx nesmí xxx xxxxxxxxxxx xxxxx než 2,5 %. |
||
Xxxxxxxxx nesmí xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxx. |
|||
5) |
xxxxxx |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,1 % xxxxxxx. |
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx xxxxx přesáhnout 0,2 %. |
b) |
Dále mohou xxxxxxxxx xxxxx nebo xxxx xxxxxxx xxxxx (xxxxxxx xxxx omamných). |
||
Omamná xxxxx x přípravku xxxxxxxx xxxxx xxx xxxxxx získána zpět x takovém xxxxxxxx, xxx xxxxxxxx xxxxxxx xxxxxx |
|||
7) |
xxxxxxxxxxxxx xxxxxx x xxxxx |
x) |
Xxxxxxxx xxxx v xxxxxx xxxxx xxx xxxxx než 10 %. |
x) |
Xxxxxxxx xxxxxxxxxxxxxxx xxxxxx xxxxx být vyšší xxx 10 %. |
||
x} |
Xxxxxxxx xxxxx xxxx xxxx xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxxx) xxxxx xxx nižší xxx 80%. |
||
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxx 100 xx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v xxxx Xxxxxx xxxxx. |
x) |
Xxxxxxxxx methylcelulosy x přípravku xxxx xxx xxxxxxx stejné xxxx vyšší xxx xxxxxxxxx. |
Xxxxxx homeopaticky xxxxxxxxxx xxxxxxxxx, xxxxxxx xxxxxx xxxxxx xx xxxxx xxx X4 xxxx XX2.
Xx. XX
Xxxx xxxxxxxx xxxx oznámeno v xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x oblasti xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 46/2017 Xx. x účinností xx 1.3.2017
Čl. XX
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx poskytování xxxxxxxxx v xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx služby xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 30/2018 Sb. x účinností xx 8.3.2018
Xx. XX
Xxxx nařízení xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx v xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx právním xxxxxxxxx x. 242/2018 Sb. x xxxxxxxxx od 25.10.2018
Xx. XX
Xxxxxxxxx předpis
Toto xxxxxxxx xxxx oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx parlamentu x Rady (EU) 2015/1535 ze xxx 9. září 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 184/2021 Xx. s účinností xx 3.6.2021
Čl. II
Technický xxxxxxx
Xxxx xxxxxxxx xxxx oznámeno x souladu xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 xx dne 9. xxxx 2015 x postupu při xxxxxxxxxxx informací v xxxxxxx technických xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 159/2022 Xx. x účinností xx 1.7.2022
Xx. II
Technický xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (EU) 2015/1535 ze dne 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx technických předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX vložen xxxxxxx xxxxxxxxx x. 228/2023 Xx. x účinností xx 1.8.2023
Xx. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x souladu se xxxxxxxx Evropského xxxxxxxxxx x Xxxx (EU) 2015/1535 xx dne 9. září 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx technických xxxxxxxx x xxxxxxxx pro xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 52/2024 Xx. s účinností xx 6.3.2024
Čl. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Evropského parlamentu x Rady (XX) 2015/1535 ze xxx 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx v xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 176/2024 Xx. s xxxxxxxxx xx 1.7.2024
Čl. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 xx xxx 9. září 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 419/2024 Xx. x xxxxxxxxx xx 1.1.2025
Xxxxxx xxxxxxx x. 463/2013 Sb. nabyl xxxxxxxxx xxxx 1.1.2014.
Xx xxxxx tohoto právního xxxxxxxx xxxx podchyceny xxxxx x xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
243/2015 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek
s xxxxxxxxx xx 1.10.2015
46/2017 Sb., xxxxxx se xxxx xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxx xxxxx č. 243/2015 Xx.
x xxxxxxxxx xx 1.3.2017 x xxxxxxxx xxxxxxxxx ustanovení, xxxxx xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., xxxxxx xx xxxx nařízení vlády x. 463/2013 Sb., x seznamech návykových xxxxx, ve znění xxxxxxxxxx xxxxxxxx
x účinností xx 8.3.2018
242/2018 Xx., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Xx., o xxxxxxxxx návykových xxxxx, xx znění pozdějších xxxxxxxx
x xxxxxxxxx xx 25.10.2018
184/2021 Xx., xxxxxx xx mění xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 3.6.2021
159/2022 Xx., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech návykových xxxxx, ve xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 1.7.2022
228/2023 Sb., xxxxxx xx mění xxxxxxxx xxxxx č. 463/2013 Sb., o xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.8.2023
52/2024 Sb., xxxxxx xx mění xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx se mění xxxxxxxx vlády x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 1.7.2024 x 1.1.2025
419/2024 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx předpisů
s účinností xx 1.1.2025 x 1.4.2025
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx jich netýká xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.
1) Xxxxxxxx xxxxxx x xxxxxxxx látkách, xxxxxxxxx pod č. 47/1965 Sb., xx znění Protokolu x xxxxxxx Xxxxxxxx xxxxxx o xxxxxxxx xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2022/1326 xx xxx 18. xxxxxx 2022, xxxxxx xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX, pokud xxx o xxxxxxxx xxxxxx psychoaktivních látek xx xxxxxxxx xxxxx.
2) Xxxxxx x xxxxxxxxxxxxxx xxxxxxx, xxxxxxxxx xxx č. 62/1989 Sb.
3) Xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX xx xxx 25. xxxxx 2004, kterým se xxxxxxx minimální xxxxxxxxxx xxxxxxxx se xxxxx xxxxxxxxxx podstat xxxxxxxxx xxxx a xxxxxx x xxxxxxx xxxxxxxxxxxx xxxxxxx x drogami.
Směrnice Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2017/2103 xx dne 15. xxxxxxxxx 2017, kterou xx xxxx xxxxxxx xxxxxxxxxx Rady 2004/757/XXX x xxxxx xxxxxxxx xx definice drogy xxxx xxxxxxxxxxxxx xxxxx x xxxxxxx xxxxxxxxxx Xxxx 2005/387/XXX.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2019/369 xx xxx 13. prosince 2018, kterou xx xxxx xxxxxxx rámcového xxxxxxxxxx Rady 2004/757/XXX, xxxxx xxx o xxxxxxxx nových xxxxxxxxxxxxxxx xxxxx xx definice xxxxx.
Xxxxxxxx Xxxxxx x xxxxxxxxx pravomoci (XX) 2020/1687 ze dne 2. xxxx 2020, xxxxxx xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/SVV, xxxxx xxx x xxxxxxxx xxxx psychoaktivní xxxxx X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1 H-benzimidazol-1-ethanamin (isotonitazen) xx xxxxxxxx drogy.
Směrnice Xxxxxx v xxxxxxxxx xxxxxxxxx (EU) 2021/802 xx xxx 12. xxxxxx 2021, xxxxxx xx xxxx příloha xxxxxxxxx xxxxxxxxxx Rady 2004/757/XXX, xxxxx xxx x zahrnutí xxxxxx xxxxxxxxxxxxxxx xxxxx methyl 3,3-xxxxxxxx-2-{[1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx} xxxxxxxx (XXXX-4xx-XXXXXX) x xxxxxx 2-{[1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx (4X-XXXX-XXXX) do xxxxxxxx xxxxx.